| Dear Fellow Trader, |
| I hope you are having a great Friday and also hope you have a good weekend ahead of you! I am sending you the list of major stocks reporting Earnings before the market opens on the next trading day. So you can have enough time to trade Pre-Earnings strategy or hedge your existing position(s) before they report Earnings. It also includes '% Predicted Volatility After Earnings Announcement'. |
The Next Antiviral Leader That Could Disrupt Multi-Billion Markets (ad)*
NanoViricides (NYSE: NNVC) is pioneering a new era in antiviral medicine with NV-387, a broad-spectrum antiviral currently in Phase II trials. Unlike traditional drugs, NV-387 can neutralize multiple viruses — from Influenza and RSV to COVID-19 and MPox — without first identifying the culprit. Backed by strong safety data and animal models showing superior efficacy to existing treatments, NV-387 could reshape how viral infections are managed globally. With potential orphan drug designations and a growing antiviral pipeline, NNVC is positioned for explosive growth in a multi-billion-dollar market.
💡 Discover how NV-387 could transform viral treatment — and investor portfolios alike. |
|
 | Before Market Open |  | After Market Close | |
| *Predicted Volatility % based on our Proprietary Volatility Predication Model. We are expecting that stock price will likely to reach % in either direction by the end of next trading session after Earnings are released and not necessarily the closing volatility %. |
Forget Tesla — This Tiny AI Stock Is Musk's Real Play (ad)
While Wall Street focused on Tesla's earnings, Elon Musk was quietly building a supercomputer so powerful it could transform warfare, robotics, and the global economy. But you don't need to buy Tesla or wait for xAI to IPO to benefit. One overlooked public company is supplying the critical tech behind Musk's AI push — and it trades for a fraction of Nvidia's price. Hedge funds are already loading up, but most investors haven't noticed yet.
See the full details on this "backdoor" Musk bet here. |
💰 A Tiny Biotech Poised to Disrupt the $100B+ Antiviral Market (ad)*
NanoViricides, Inc. (NYSE: NNVC) may be the small biotech about to make the biggest antiviral leap in decades. Its breakthrough drug NV-387 targets a multi-billion-dollar market by treating viral infections without needing to know which virus caused them. Currently in Phase II trials, NV-387 has shown remarkable results against Influenza, COVID-19, RSV, and MPox, with excellent safety in humans. Add orphan drug benefits and Priority Review Voucher potential, and NNVC could soon stand among major pharma names. Investors are taking notice — and this could be just the beginning.
📈 Learn how NNVC could disrupt the global antiviral industry. |
| How to use Predicted Volatility in your trading strategies: |
| Options Trading - You can use Volatility Rush strategies (buying straddle three weeks before earnings dates) for stocks which have more than 5% predicted volatility. Please click on Volatility Rush Trading Strategy to learn more about it. You can use Volatility Crush trading strategy for major stocks with Predicted Volatility less than 4%. Please click on Volatility Crush Strategy to learn more about it.You can use Ride-the-Wave to targets multi-day price momentum following a company's earnings announcement (EA). Please click on Ride-the-Wave Strategy to learn more about it. |
| Stock Trading - If you're a stock trader or portfolio manager, you want to avoid an unexpected loss based on a surprise negative earnings announcement (you don't want to wake up on the morning of an earnings announcement and see your portfolio down by 10 percent or more). |
| The key to avoiding this kind of loss is knowing a stock's historical earnings-related volatility well before it announces earnings. Armed with that knowledge, you'll have enough time to design a hedging strategy that will protect you from a big drop caused by a negative earnings announcement. |
| At StockEarnings, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader. |
| To your trading success, |
| Hiral Ghelani |
| Founder & CEO |
| StockEarnings, Inc |
| 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA |
| W: 877.6.STOCKS (Mon to Sat | 9am to 5pm EST | Feel Free to Call Us) |
| |
|
| (ad)* This message is a PAID ADVERTISEMENT for NanoViricides, Inc (NYSE: NNVC) from Interactive Offers. StockEarnings, Inc. has received a fixed fee of $7,000 from Interactive Offers for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between Oct 24, 2025 and Oct 30, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either NanoViricides, Inc (NYSE: NNVC) or Interactive Offers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding NanoViricides, Inc (NYSE: NNVC) on Smallcaps Daily website for additional information about the relationship between Interactive Offers and NanoViricides, Inc (NYSE: NNVC). StockEarnings, Inc (SE) is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers. StockEarnings Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | W: 877.6.STOCKS |
Unsubscribe
Today's Bonus Content: Washington's richest don't follow the market - they move it
|
